Tom Frohlich, Chief Operating Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 47,540 shares at $14.00 ($698K) on 2021-11-05, disclosed to the SEC on 2021-11-09.
Open-market sale of $698k KDNY by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 5,000 | $70K | 10.0% |
| 2 | $14.00 | 15,000 | $210K | 30.1% |
| 3 | $15.17 | 13,770 | $209K | 29.9% |
| 4 | $15.17 | 13,770 | $209K | 29.9% |
| Total | $14.68 avg | 47,540 | $698K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-02 | $225K | — | Filing → |
| KDNY | SELL | 2022-12-15 | $250K | — | Filing → |
| KDNY | SELL | 2022-11-09 | $222K | — | Filing → |